nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.152	0.248	CbGbCtD
Temozolomide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.115	0.188	CbGbCtD
Temozolomide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0988	0.161	CbGbCtD
Temozolomide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0974	0.159	CbGbCtD
Temozolomide—CYP3A4—Prednisone—ankylosing spondylitis	0.092	0.15	CbGbCtD
Temozolomide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0575	0.0938	CbGbCtD
Temozolomide—Angioedema—Betamethasone—ankylosing spondylitis	0.000468	0.00121	CcSEcCtD
Temozolomide—Angioedema—Dexamethasone—ankylosing spondylitis	0.000468	0.00121	CcSEcCtD
Temozolomide—Stomatitis—Methotrexate—ankylosing spondylitis	0.000465	0.0012	CcSEcCtD
Temozolomide—Angiopathy—Prednisone—ankylosing spondylitis	0.000465	0.0012	CcSEcCtD
Temozolomide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000463	0.0012	CcSEcCtD
Temozolomide—Immune system disorder—Prednisone—ankylosing spondylitis	0.000463	0.00119	CcSEcCtD
Temozolomide—Malaise—Dexamethasone—ankylosing spondylitis	0.000462	0.00119	CcSEcCtD
Temozolomide—Malaise—Betamethasone—ankylosing spondylitis	0.000462	0.00119	CcSEcCtD
Temozolomide—Oedema—Triamcinolone—ankylosing spondylitis	0.000461	0.00119	CcSEcCtD
Temozolomide—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000461	0.00119	CcSEcCtD
Temozolomide—Vertigo—Betamethasone—ankylosing spondylitis	0.00046	0.00119	CcSEcCtD
Temozolomide—Vertigo—Dexamethasone—ankylosing spondylitis	0.00046	0.00119	CcSEcCtD
Temozolomide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000459	0.00119	CcSEcCtD
Temozolomide—Infection—Triamcinolone—ankylosing spondylitis	0.000458	0.00118	CcSEcCtD
Temozolomide—Infection—Methylprednisolone—ankylosing spondylitis	0.000456	0.00118	CcSEcCtD
Temozolomide—Insomnia—Prednisolone—ankylosing spondylitis	0.000453	0.00117	CcSEcCtD
Temozolomide—Alopecia—Prednisone—ankylosing spondylitis	0.000453	0.00117	CcSEcCtD
Temozolomide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000451	0.00116	CcSEcCtD
Temozolomide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000451	0.00116	CcSEcCtD
Temozolomide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00045	0.00116	CcSEcCtD
Temozolomide—Mental disorder—Prednisone—ankylosing spondylitis	0.000449	0.00116	CcSEcCtD
Temozolomide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000446	0.00115	CcSEcCtD
Temozolomide—Malnutrition—Prednisone—ankylosing spondylitis	0.000446	0.00115	CcSEcCtD
Temozolomide—Erythema—Prednisone—ankylosing spondylitis	0.000446	0.00115	CcSEcCtD
Temozolomide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000445	0.00115	CcSEcCtD
Temozolomide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000444	0.00115	CcSEcCtD
Temozolomide—Convulsion—Betamethasone—ankylosing spondylitis	0.000444	0.00115	CcSEcCtD
Temozolomide—Convulsion—Dexamethasone—ankylosing spondylitis	0.000444	0.00115	CcSEcCtD
Temozolomide—Hypertension—Dexamethasone—ankylosing spondylitis	0.000442	0.00114	CcSEcCtD
Temozolomide—Hypertension—Betamethasone—ankylosing spondylitis	0.000442	0.00114	CcSEcCtD
Temozolomide—Myalgia—Dexamethasone—ankylosing spondylitis	0.000436	0.00113	CcSEcCtD
Temozolomide—Myalgia—Betamethasone—ankylosing spondylitis	0.000436	0.00113	CcSEcCtD
Temozolomide—Anxiety—Betamethasone—ankylosing spondylitis	0.000434	0.00112	CcSEcCtD
Temozolomide—Anxiety—Dexamethasone—ankylosing spondylitis	0.000434	0.00112	CcSEcCtD
Temozolomide—Discomfort—Betamethasone—ankylosing spondylitis	0.000431	0.00111	CcSEcCtD
Temozolomide—Discomfort—Dexamethasone—ankylosing spondylitis	0.000431	0.00111	CcSEcCtD
Temozolomide—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00043	0.00111	CcSEcCtD
Temozolomide—Pain—Prednisolone—ankylosing spondylitis	0.000428	0.00111	CcSEcCtD
Temozolomide—Hepatitis—Methotrexate—ankylosing spondylitis	0.000428	0.00111	CcSEcCtD
Temozolomide—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000428	0.00111	CcSEcCtD
Temozolomide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000425	0.0011	CcSEcCtD
Temozolomide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000423	0.00109	CcSEcCtD
Temozolomide—Vision blurred—Prednisone—ankylosing spondylitis	0.00042	0.00108	CcSEcCtD
Temozolomide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00042	0.00108	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00042	0.00108	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000419	0.00108	CcSEcCtD
Temozolomide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000418	0.00108	CcSEcCtD
Temozolomide—Oedema—Dexamethasone—ankylosing spondylitis	0.000418	0.00108	CcSEcCtD
Temozolomide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000418	0.00108	CcSEcCtD
Temozolomide—Oedema—Betamethasone—ankylosing spondylitis	0.000418	0.00108	CcSEcCtD
Temozolomide—Insomnia—Triamcinolone—ankylosing spondylitis	0.000417	0.00108	CcSEcCtD
Temozolomide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000416	0.00107	CcSEcCtD
Temozolomide—Infection—Betamethasone—ankylosing spondylitis	0.000415	0.00107	CcSEcCtD
Temozolomide—Infection—Dexamethasone—ankylosing spondylitis	0.000415	0.00107	CcSEcCtD
Temozolomide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000414	0.00107	CcSEcCtD
Temozolomide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000414	0.00107	CcSEcCtD
Temozolomide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000413	0.00107	CcSEcCtD
Temozolomide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000413	0.00107	CcSEcCtD
Temozolomide—Visual impairment—Methotrexate—ankylosing spondylitis	0.000413	0.00106	CcSEcCtD
Temozolomide—Anaemia—Prednisone—ankylosing spondylitis	0.000412	0.00106	CcSEcCtD
Temozolomide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000411	0.00106	CcSEcCtD
Temozolomide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00041	0.00106	CcSEcCtD
Temozolomide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00041	0.00106	CcSEcCtD
Temozolomide—Agitation—Prednisone—ankylosing spondylitis	0.00041	0.00106	CcSEcCtD
Temozolomide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000409	0.00106	CcSEcCtD
Temozolomide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000409	0.00106	CcSEcCtD
Temozolomide—Angioedema—Prednisone—ankylosing spondylitis	0.000407	0.00105	CcSEcCtD
Temozolomide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000405	0.00105	CcSEcCtD
Temozolomide—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000405	0.00104	CcSEcCtD
Temozolomide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000404	0.00104	CcSEcCtD
Temozolomide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000404	0.00104	CcSEcCtD
Temozolomide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000404	0.00104	CcSEcCtD
Temozolomide—Malaise—Prednisone—ankylosing spondylitis	0.000402	0.00104	CcSEcCtD
Temozolomide—Vertigo—Prednisone—ankylosing spondylitis	0.000401	0.00103	CcSEcCtD
Temozolomide—Eye disorder—Methotrexate—ankylosing spondylitis	0.0004	0.00103	CcSEcCtD
Temozolomide—Tinnitus—Methotrexate—ankylosing spondylitis	0.000399	0.00103	CcSEcCtD
Temozolomide—Anorexia—Betamethasone—ankylosing spondylitis	0.000398	0.00103	CcSEcCtD
Temozolomide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000398	0.00103	CcSEcCtD
Temozolomide—Urticaria—Prednisolone—ankylosing spondylitis	0.000398	0.00103	CcSEcCtD
Temozolomide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000397	0.00103	CcSEcCtD
Temozolomide—Fatigue—Triamcinolone—ankylosing spondylitis	0.000397	0.00102	CcSEcCtD
Temozolomide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000396	0.00102	CcSEcCtD
Temozolomide—Pain—Triamcinolone—ankylosing spondylitis	0.000394	0.00102	CcSEcCtD
Temozolomide—Angiopathy—Methotrexate—ankylosing spondylitis	0.000388	0.001	CcSEcCtD
Temozolomide—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000387	0.000998	CcSEcCtD
Temozolomide—Convulsion—Prednisone—ankylosing spondylitis	0.000386	0.000997	CcSEcCtD
Temozolomide—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000386	0.000996	CcSEcCtD
Temozolomide—Hypertension—Prednisone—ankylosing spondylitis	0.000385	0.000994	CcSEcCtD
Temozolomide—Chills—Methotrexate—ankylosing spondylitis	0.000384	0.000991	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000381	0.000983	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000381	0.000983	CcSEcCtD
Temozolomide—Arthralgia—Prednisone—ankylosing spondylitis	0.00038	0.00098	CcSEcCtD
Temozolomide—Myalgia—Prednisone—ankylosing spondylitis	0.00038	0.00098	CcSEcCtD
Temozolomide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000379	0.00098	CcSEcCtD
Temozolomide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000379	0.000977	CcSEcCtD
Temozolomide—Anxiety—Prednisone—ankylosing spondylitis	0.000378	0.000977	CcSEcCtD
Temozolomide—Alopecia—Methotrexate—ankylosing spondylitis	0.000378	0.000976	CcSEcCtD
Temozolomide—Insomnia—Betamethasone—ankylosing spondylitis	0.000378	0.000976	CcSEcCtD
Temozolomide—Insomnia—Dexamethasone—ankylosing spondylitis	0.000378	0.000976	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000377	0.000973	CcSEcCtD
Temozolomide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000376	0.00097	CcSEcCtD
Temozolomide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000375	0.000969	CcSEcCtD
Temozolomide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000375	0.000969	CcSEcCtD
Temozolomide—Discomfort—Prednisone—ankylosing spondylitis	0.000375	0.000968	CcSEcCtD
Temozolomide—Mental disorder—Methotrexate—ankylosing spondylitis	0.000375	0.000968	CcSEcCtD
Temozolomide—Erythema—Methotrexate—ankylosing spondylitis	0.000373	0.000962	CcSEcCtD
Temozolomide—Malnutrition—Methotrexate—ankylosing spondylitis	0.000373	0.000962	CcSEcCtD
Temozolomide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000369	0.000952	CcSEcCtD
Temozolomide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000368	0.00095	CcSEcCtD
Temozolomide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000368	0.00095	CcSEcCtD
Temozolomide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000366	0.000944	CcSEcCtD
Temozolomide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000365	0.000942	CcSEcCtD
Temozolomide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000365	0.000942	CcSEcCtD
Temozolomide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000364	0.00094	CcSEcCtD
Temozolomide—Oedema—Prednisone—ankylosing spondylitis	0.000364	0.000939	CcSEcCtD
Temozolomide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000364	0.000939	CcSEcCtD
Temozolomide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000363	0.000938	CcSEcCtD
Temozolomide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000363	0.000938	CcSEcCtD
Temozolomide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000363	0.000938	CcSEcCtD
Temozolomide—Infection—Prednisone—ankylosing spondylitis	0.000362	0.000933	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000361	0.000931	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000361	0.000931	CcSEcCtD
Temozolomide—Back pain—Methotrexate—ankylosing spondylitis	0.00036	0.00093	CcSEcCtD
Temozolomide—Fatigue—Betamethasone—ankylosing spondylitis	0.00036	0.00093	CcSEcCtD
Temozolomide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00036	0.00093	CcSEcCtD
Temozolomide—Pain—Betamethasone—ankylosing spondylitis	0.000357	0.000922	CcSEcCtD
Temozolomide—Pain—Dexamethasone—ankylosing spondylitis	0.000357	0.000922	CcSEcCtD
Temozolomide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000357	0.000921	CcSEcCtD
Temozolomide—Skin disorder—Prednisone—ankylosing spondylitis	0.000353	0.000912	CcSEcCtD
Temozolomide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000352	0.000908	CcSEcCtD
Temozolomide—Vision blurred—Methotrexate—ankylosing spondylitis	0.000351	0.000907	CcSEcCtD
Temozolomide—Anorexia—Prednisone—ankylosing spondylitis	0.000347	0.000895	CcSEcCtD
Temozolomide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000346	0.000893	CcSEcCtD
Temozolomide—Anaemia—Methotrexate—ankylosing spondylitis	0.000344	0.000889	CcSEcCtD
Temozolomide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000344	0.000889	CcSEcCtD
Temozolomide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000344	0.000889	CcSEcCtD
Temozolomide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000342	0.000882	CcSEcCtD
Temozolomide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000342	0.000882	CcSEcCtD
Temozolomide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000339	0.000876	CcSEcCtD
Temozolomide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000339	0.000874	CcSEcCtD
Temozolomide—Malaise—Methotrexate—ankylosing spondylitis	0.000336	0.000867	CcSEcCtD
Temozolomide—Vertigo—Methotrexate—ankylosing spondylitis	0.000335	0.000864	CcSEcCtD
Temozolomide—Leukopenia—Methotrexate—ankylosing spondylitis	0.000334	0.000861	CcSEcCtD
Temozolomide—Urticaria—Betamethasone—ankylosing spondylitis	0.000332	0.000857	CcSEcCtD
Temozolomide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000332	0.000857	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000332	0.000856	CcSEcCtD
Temozolomide—Dizziness—Prednisolone—ankylosing spondylitis	0.000331	0.000855	CcSEcCtD
Temozolomide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00033	0.000853	CcSEcCtD
Temozolomide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00033	0.000853	CcSEcCtD
Temozolomide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00033	0.000853	CcSEcCtD
Temozolomide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00033	0.000853	CcSEcCtD
Temozolomide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00033	0.000853	CcSEcCtD
Temozolomide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00033	0.000851	CcSEcCtD
Temozolomide—Insomnia—Prednisone—ankylosing spondylitis	0.000329	0.00085	CcSEcCtD
Temozolomide—Paraesthesia—Prednisone—ankylosing spondylitis	0.000327	0.000844	CcSEcCtD
Temozolomide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000326	0.000841	CcSEcCtD
Temozolomide—Cough—Methotrexate—ankylosing spondylitis	0.000325	0.000839	CcSEcCtD
Temozolomide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000325	0.000839	CcSEcCtD
Temozolomide—Convulsion—Methotrexate—ankylosing spondylitis	0.000323	0.000833	CcSEcCtD
Temozolomide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00032	0.000827	CcSEcCtD
Temozolomide—Arthralgia—Methotrexate—ankylosing spondylitis	0.000317	0.000819	CcSEcCtD
Temozolomide—Myalgia—Methotrexate—ankylosing spondylitis	0.000317	0.000819	CcSEcCtD
Temozolomide—Decreased appetite—Prednisone—ankylosing spondylitis	0.000316	0.000817	CcSEcCtD
Temozolomide—Rash—Prednisolone—ankylosing spondylitis	0.000316	0.000815	CcSEcCtD
Temozolomide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000315	0.000814	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000315	0.000813	CcSEcCtD
Temozolomide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000314	0.000812	CcSEcCtD
Temozolomide—Fatigue—Prednisone—ankylosing spondylitis	0.000314	0.00081	CcSEcCtD
Temozolomide—Headache—Prednisolone—ankylosing spondylitis	0.000314	0.00081	CcSEcCtD
Temozolomide—Discomfort—Methotrexate—ankylosing spondylitis	0.000313	0.000809	CcSEcCtD
Temozolomide—Constipation—Prednisone—ankylosing spondylitis	0.000311	0.000803	CcSEcCtD
Temozolomide—Confusional state—Methotrexate—ankylosing spondylitis	0.000307	0.000792	CcSEcCtD
Temozolomide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000305	0.000786	CcSEcCtD
Temozolomide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000304	0.000785	CcSEcCtD
Temozolomide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000304	0.000784	CcSEcCtD
Temozolomide—Infection—Methotrexate—ankylosing spondylitis	0.000302	0.00078	CcSEcCtD
Temozolomide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.0003	0.000774	CcSEcCtD
Temozolomide—Asthenia—Dexamethasone—ankylosing spondylitis	0.0003	0.000774	CcSEcCtD
Temozolomide—Asthenia—Betamethasone—ankylosing spondylitis	0.0003	0.000774	CcSEcCtD
Temozolomide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000298	0.00077	CcSEcCtD
Temozolomide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000298	0.000769	CcSEcCtD
Temozolomide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000298	0.000768	CcSEcCtD
Temozolomide—Nausea—Prednisolone—ankylosing spondylitis	0.000297	0.000768	CcSEcCtD
Temozolomide—Pruritus—Betamethasone—ankylosing spondylitis	0.000296	0.000763	CcSEcCtD
Temozolomide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000296	0.000763	CcSEcCtD
Temozolomide—Skin disorder—Methotrexate—ankylosing spondylitis	0.000295	0.000763	CcSEcCtD
Temozolomide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000294	0.000759	CcSEcCtD
Temozolomide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000293	0.000756	CcSEcCtD
Temozolomide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000292	0.000754	CcSEcCtD
Temozolomide—Rash—Triamcinolone—ankylosing spondylitis	0.00029	0.00075	CcSEcCtD
Temozolomide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00029	0.000749	CcSEcCtD
Temozolomide—Anorexia—Methotrexate—ankylosing spondylitis	0.00029	0.000748	CcSEcCtD
Temozolomide—Rash—Methylprednisolone—ankylosing spondylitis	0.00029	0.000748	CcSEcCtD
Temozolomide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000289	0.000747	CcSEcCtD
Temozolomide—Urticaria—Prednisone—ankylosing spondylitis	0.000289	0.000746	CcSEcCtD
Temozolomide—Headache—Triamcinolone—ankylosing spondylitis	0.000288	0.000745	CcSEcCtD
Temozolomide—Headache—Methylprednisolone—ankylosing spondylitis	0.000288	0.000743	CcSEcCtD
Temozolomide—Abdominal pain—Prednisone—ankylosing spondylitis	0.000288	0.000743	CcSEcCtD
Temozolomide—Body temperature increased—Prednisone—ankylosing spondylitis	0.000288	0.000743	CcSEcCtD
Temozolomide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000286	0.000738	CcSEcCtD
Temozolomide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000286	0.000738	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000277	0.000715	CcSEcCtD
Temozolomide—Dizziness—Dexamethasone—ankylosing spondylitis	0.000276	0.000713	CcSEcCtD
Temozolomide—Dizziness—Betamethasone—ankylosing spondylitis	0.000276	0.000713	CcSEcCtD
Temozolomide—Insomnia—Methotrexate—ankylosing spondylitis	0.000275	0.00071	CcSEcCtD
Temozolomide—Nausea—Triamcinolone—ankylosing spondylitis	0.000274	0.000706	CcSEcCtD
Temozolomide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000273	0.000705	CcSEcCtD
Temozolomide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000273	0.000705	CcSEcCtD
Temozolomide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000271	0.0007	CcSEcCtD
Temozolomide—Somnolence—Methotrexate—ankylosing spondylitis	0.00027	0.000698	CcSEcCtD
Temozolomide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000268	0.000692	CcSEcCtD
Temozolomide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000268	0.000691	CcSEcCtD
Temozolomide—Vomiting—Betamethasone—ankylosing spondylitis	0.000266	0.000686	CcSEcCtD
Temozolomide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000266	0.000686	CcSEcCtD
Temozolomide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000264	0.000682	CcSEcCtD
Temozolomide—Rash—Dexamethasone—ankylosing spondylitis	0.000263	0.00068	CcSEcCtD
Temozolomide—Rash—Betamethasone—ankylosing spondylitis	0.000263	0.00068	CcSEcCtD
Temozolomide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000263	0.000679	CcSEcCtD
Temozolomide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000263	0.000679	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000263	0.000678	CcSEcCtD
Temozolomide—Fatigue—Methotrexate—ankylosing spondylitis	0.000262	0.000677	CcSEcCtD
Temozolomide—Headache—Dexamethasone—ankylosing spondylitis	0.000262	0.000676	CcSEcCtD
Temozolomide—Headache—Betamethasone—ankylosing spondylitis	0.000262	0.000676	CcSEcCtD
Temozolomide—Asthenia—Prednisone—ankylosing spondylitis	0.000261	0.000674	CcSEcCtD
Temozolomide—Pain—Methotrexate—ankylosing spondylitis	0.00026	0.000671	CcSEcCtD
Temozolomide—Pruritus—Prednisone—ankylosing spondylitis	0.000257	0.000665	CcSEcCtD
Temozolomide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000251	0.000647	CcSEcCtD
Temozolomide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000249	0.000643	CcSEcCtD
Temozolomide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000249	0.000642	CcSEcCtD
Temozolomide—Nausea—Betamethasone—ankylosing spondylitis	0.000248	0.000641	CcSEcCtD
Temozolomide—Nausea—Dexamethasone—ankylosing spondylitis	0.000248	0.000641	CcSEcCtD
Temozolomide—Urticaria—Methotrexate—ankylosing spondylitis	0.000242	0.000624	CcSEcCtD
Temozolomide—Dizziness—Prednisone—ankylosing spondylitis	0.000241	0.000621	CcSEcCtD
Temozolomide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00024	0.000621	CcSEcCtD
Temozolomide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00024	0.000621	CcSEcCtD
Temozolomide—Vomiting—Prednisone—ankylosing spondylitis	0.000231	0.000597	CcSEcCtD
Temozolomide—Rash—Prednisone—ankylosing spondylitis	0.000229	0.000592	CcSEcCtD
Temozolomide—Dermatitis—Prednisone—ankylosing spondylitis	0.000229	0.000592	CcSEcCtD
Temozolomide—Headache—Prednisone—ankylosing spondylitis	0.000228	0.000588	CcSEcCtD
Temozolomide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000224	0.000578	CcSEcCtD
Temozolomide—Asthenia—Methotrexate—ankylosing spondylitis	0.000218	0.000563	CcSEcCtD
Temozolomide—Nausea—Prednisone—ankylosing spondylitis	0.000216	0.000558	CcSEcCtD
Temozolomide—Pruritus—Methotrexate—ankylosing spondylitis	0.000215	0.000555	CcSEcCtD
Temozolomide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000208	0.000537	CcSEcCtD
Temozolomide—Dizziness—Methotrexate—ankylosing spondylitis	0.000201	0.000519	CcSEcCtD
Temozolomide—Vomiting—Methotrexate—ankylosing spondylitis	0.000193	0.000499	CcSEcCtD
Temozolomide—Rash—Methotrexate—ankylosing spondylitis	0.000192	0.000495	CcSEcCtD
Temozolomide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000192	0.000495	CcSEcCtD
Temozolomide—Headache—Methotrexate—ankylosing spondylitis	0.000191	0.000492	CcSEcCtD
Temozolomide—Nausea—Methotrexate—ankylosing spondylitis	0.000181	0.000466	CcSEcCtD
